Literature DB >> 27483478

Borrowing (once again) from the animal kingdom.

Leonardo Pasalic1, Emmanuel J Favaloro1.   

Abstract

Year:  2016        PMID： 27483478      PMCID： PMC5490723          DOI： 10.2450/2016.0104-16

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  23 in total

1.  The principal results of the International Immune Tolerance Study: a randomized dose comparison.

Authors:  Charles R M Hay; Donna M DiMichele
Journal:  Blood       Date:  2011-11-18       Impact factor: 22.113

2.  Porcine factor VIII.

Authors:  P L F Giangrande
Journal:  Haemophilia       Date:  2012-05       Impact factor: 4.287

Review 3.  Porcine factor VIII: current status and future developments.

Authors:  C R M Hay
Journal:  Haemophilia       Date:  2002-01       Impact factor: 4.287

4.  Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  Peter W Collins; Sybil Hirsch; Trevor P Baglin; Gerard Dolan; John Hanley; Michael Makris; David M Keeling; Ri Liesner; Simon A Brown; Charles R M Hay
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

Review 5.  Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.

Authors:  Pier Mannuccio Mannucci; Massimo Franchini
Journal:  Blood Transfus       Date:  2016-07-25       Impact factor: 3.443

6.  Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.

Authors:  C L Kempton; T C Abshire; R A Deveras; W K Hoots; J C Gill; C M Kessler; N S Key; B A Konkle; P Kuriakose; D E Macfarlane; G Bergman
Journal:  Haemophilia       Date:  2012-04-19       Impact factor: 4.287

7.  Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate.

Authors:  J M Soucie; D D Erdman; B L Evatt; L J Anderson; T J Török; M El-Jamil; E Barnhart; M Tepper; H N Burrill; A M Pickett; W L Mengeling
Journal:  Transfusion       Date:  2000-06       Impact factor: 3.157

8.  The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99.

Authors:  S C Darby; D M Keeling; R J D Spooner; S Wan Kan; P L F Giangrande; P W Collins; F G H Hill; C R M Hay
Journal:  J Thromb Haemost       Date:  2004-07       Impact factor: 5.824

Review 9.  The Judicious Use of Recombinant Factor VIIa.

Authors:  Lawrence Tim Goodnough; Jerrold H Levy
Journal:  Semin Thromb Hemost       Date:  2016-02-02       Impact factor: 4.180

10.  Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A.

Authors:  R Kruse-Jarres; J St-Louis; A Greist; A Shapiro; H Smith; P Chowdary; A Drebes; E Gomperts; C Bourgeois; M Mo; A Novack; H Farin; B Ewenstein
Journal:  Haemophilia       Date:  2015-01-27       Impact factor: 4.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.